Exos TFP Holdings’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-309,467
Closed -$13K 717
2022
Q3
$13K Buy
+309,467
New +$28K 0.01% 360

Exos TFP Holdings's ACII.WS Position: Q4 2022 in Review

Exos TFP Holdings sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q4 2022, closing a stake of 309,467 shares — an estimated $13K sold.

Exos TFP Holdings first reported a position in ACII.WS in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 0 funds tracked by Wall St. Rank hold ACII.WS as of Q4 2022.

  • Exos TFP Holdings reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Exos TFP Holdings sold 309,467 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $13K.
  • Exos TFP Holdings first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Exos TFP Holdings's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $13K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on Exos TFP Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.